29 julio 2014
An important advancement toward developing a vaccine against the debilitating and potentially deadly tick-transmitted disease, human granulocytic anaplasmosis has been made by scientists. Successful vaccine development hinges on knowing what to target to prevent disease, and the research team has identified three such proteins on the surface of the HGA agent.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/x0FSf2UVVx8/140729152923.htm
